A. Vakrinou Et Al. , "Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in clinical practice," Journal of Neurology, Neurosurgery and Psychiatry , vol.94, no.11, pp.887-892, 2023
Vakrinou, A. Et Al. 2023. Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in clinical practice. Journal of Neurology, Neurosurgery and Psychiatry , vol.94, no.11 , 887-892.
Vakrinou, A., Bellampalli, R., Gulcebi, M., Martins Custodio, H., Research Consortium, G. E., Balestrini, S., ... Sisodiya, S. M.(2023). Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in clinical practice. Journal of Neurology, Neurosurgery and Psychiatry , vol.94, no.11, 887-892.
Vakrinou, Angeliki Et Al. "Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in clinical practice," Journal of Neurology, Neurosurgery and Psychiatry , vol.94, no.11, 887-892, 2023
Vakrinou, Angeliki Et Al. "Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in clinical practice." Journal of Neurology, Neurosurgery and Psychiatry , vol.94, no.11, pp.887-892, 2023
Vakrinou, A. Et Al. (2023) . "Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in clinical practice." Journal of Neurology, Neurosurgery and Psychiatry , vol.94, no.11, pp.887-892.
@article{article, author={Angeliki Vakrinou Et Al. }, title={Risk-conferring HLA variants in an epilepsy cohort: Benefits of multifaceted use of whole genome sequencing in clinical practice}, journal={Journal of Neurology, Neurosurgery and Psychiatry}, year=2023, pages={887-892} }